Literature DB >> 16165719

Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden.

Einar Björnsson1, Pernilla Jerlstad, Annika Bergqvist, Rolf Olsson.   

Abstract

OBJECTIVE: There are only a few data on the prevalence of drug-induced liver injury associated with fatal outcome. The aim of this study was to determine the nature and number of suspected adverse drug-induced liver disease associated with fatalities and/or liver transplantation since reporting of adverse drug reactions (ADRs) started in Sweden.
MATERIAL AND METHODS: All reports of suspected hepatic ADRs with fatal outcome received by the Swedish Adverse Drug Reactions Advisory Committee (SADRAC) from 1966 to 2002 were reviewed and causality assessed.
RESULTS: The SADRAC received 151 reports of suspected ADRs with fatal outcome from liver injury; 48 cases were either unlikely or excluded. Of the remaining 103 cases, 13 (13%) were highly probable, 48 (47%) probable and 42 (41%) possible. The median age of the 103 patients was 64 years (47-77 interquartile range (IQR)) and 59 (57%) were males. The majority of cases were classified as hepatocellular (75%), with only 15% cholestatic and 10% mixed. Halothane, paracetamol, flucloxacillin, sulfamethoxazole/trimethoprim and diclofenac were the most common drugs associated with fatal outcome. Seventeen patients underwent liver transplantation, most commonly because of paracetamol and disulfiram toxicity.
CONCLUSIONS: A wide range of suspected ADRs are associated with fatalities. Antibiotics and analgesics are associated with the greatest number of reports of deaths.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165719     DOI: 10.1080/00365520510023846

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  34 in total

1.  Jaundice due to suspected statin hepatotoxicity: a case series.

Authors:  Ottar M Bergmann; Gudjon Kristjansson; Jon G Jonasson; Einar S Björnsson
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

Review 2.  Clinical perspective: statins and the liver--harmful or helpful?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2012-05-12       Impact factor: 3.199

3.  A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.

Authors:  Casey Lynnette Overby; Jyotishman Pathak; Omri Gottesman; Krystl Haerian; Adler Perotte; Sean Murphy; Kevin Bruce; Stephanie Johnson; Jayant Talwalkar; Yufeng Shen; Steve Ellis; Iftikhar Kullo; Christopher Chute; Carol Friedman; Erwin Bottinger; George Hripcsak; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2013-07-09       Impact factor: 4.497

4.  Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

Authors:  Ayako Suzuki; Raul J Andrade; Einar Bjornsson; M Isabel Lucena; William M Lee; Nancy A Yuen; Christine M Hunt; James W Freston
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

5.  Drug therapy of inflammatory arthritis.

Authors:  Nicola J Gullick; David L Scott
Journal:  Clin Med (Lond)       Date:  2012-08       Impact factor: 2.659

6.  Aspirin and acetaminophen: should they be available over the counter?

Authors:  Kay Brune; Burkhard Hinz; Ivan Otterness
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

7.  Halothane hepatitis in Iran: a review of 59 cases.

Authors:  Payam Eghtesadi-Araghi; Amirali Sohrabpour; Homayoon Vahedi; Mehdi Saberi-Firoozi
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

Review 8.  Drug-induced liver injury in older adults.

Authors:  Sarah J Mitchell; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-12

9.  [Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].

Authors:  U Hartmann; S Schmitt; M Reuss-Borst
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

10.  Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose.

Authors:  Mary Lynn Bajt; Hui-Min Yan; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2008-05-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.